Back to the full story5 sources · AstraZeneca slides after reports of Bristol Myers merger talks leave analysts 'perplexed◆ Analytics
AstraZeneca slides after reports of Bristol Myers merger talks leave analysts 'perplexed
Deterministic text analytics computed across all 5 sources. Frequency, entity overlap, and claim overlap — computed counts only. Nothing is rated true or false.
01
Frequency Analytics
The most common words and exact phrases across every report in this cluster. Computed counts only.
Top words
astrazenecabristolmyerstalkssquibbbiggestdealpharmaceuticalmergercreate
Top phrases
bristol myersbristol myers squibbmyers squibb
02
Entity Overlap
Names detected in the report text: which appear across multiple sources, and which only one source mentions.
Across multiple sources
- AstraZeneca · 5 sources
- Bristol Myers · 2 sources
- Bristol Myers Squibb · 2 sources
Unique to one source
- Bristol · MarketWatch
- Myers Squibb · MarketWatch
- Analysts · MarketWatch
- Business · The Guardian US
- Britain’s · The Guardian US
- Pascal Soriot · The Guardian US
- Pharma · The Straits Times
- Report · The Straits Times
03
Claim Overlap
Near-identical sentences found in two or more reports, versus sentences that appear in only one. Text match only — nothing is rated true or false.
Repeated across sources
No sentence appeared in more than one source.
Appears once
- "The companies have discussed a potential merger over several months, reports say." · CNBC
- "AstraZeneca shares were slumping while Bristol-Myers Squibb was jumping on Monday on reported deal talks." · MarketWatch
- "But the big question is why these two pharmaceutical giants would want to come together in the first place." · MarketWatch
- "AstraZeneca, run by Pascal Soriot, its longtime chief executive, is the second-biggest listed company in the UK, with a market value of nearly £196bn before the news broke." · The Guardian US
- "BMS, headquartered in Princeton, New Jersey, and known for its cancer treatments, ..." · The Guardian US
- "The deal would create one of the world’s biggest pharmaceutical groups." · The Straits Times